ENHANCED INHIBITION OF HIV-1 REPLICATION IN MACROPHAGES BY ANTISENSE OLIGONUCLEOTIDES, RIBOZYMES AND ACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGS DELIVERED IN pH-SENSITIVE LIPOSOMES-Reference-Cited by-同舟云学术

ENHANCED INHIBITION OF HIV-1 REPLICATION IN MACROPHAGES BY ANTISENSE OLIGONUCLEOTIDES, RIBOZYMES AND ACYCLIC NUCLEOSIDE PHOSPHONATE ANALOGS DELIVERED IN pH-SENSITIVE LIPOSOMES

Published:2001-03-31 Issue:4-7 Volume:20 Page:515-523
ISSN:1525-7770
Container-title:Nucleosides, Nucleotides and Nucleic Acids
language:en
Short-container-title:Nucleosides, Nucleotides and Nucleic Acids

Author:

Düzgünes N.,Simões S.,Slepushkin V.,Pretzer E.,Rossi J. J.,De Clercq E.,Antao V. P.,Collins M. L.,Pedroso de Lima M. C.

Publisher

Informa UK Limited

Subject

Genetics,Molecular Medicine,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1081/NCN-100002327

Reference39 articles.

1. Antisense Nucleic Acids — Prospects for Antiviral Intervention

2. Anti-HIV therapy with antisense oligonucleotides and ribozymes: realistic approaches or expensive myths?

3. Antisense technology and prospects for therapy of viral infections and cancer

4. Düzgünes, N. 1998. “Medical Applications of Liposomes”. Edited by: Lasic, D. D. and Papahadjopoulos, D. 189–219. Amsterdam: Elsevier Science B. V.

5. Liposome-mediated delivery of antiviral agents to human immunodeficiency virus-infected cells

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antisense oligonucleotide based therapeutics and its applications against bacterial infections;Medicine in Drug Discovery;2023-12

2. Liposomes: Structure, Biomedical Applications, and Stability Parameters With Emphasis on Cholesterol;Frontiers in Bioengineering and Biotechnology;2021-09-09

3. Nanopharmaceuticals in immunology;Emerging Nanotechnologies in Immunology;2018

4. Conspectus on Nanotechnology in Oral Cancer Diagnosis and Treatment;Multifunctional Systems for Combined Delivery, Biosensing and Diagnostics;2017

5. Lipid-Based Drug Delivery Systems in Cancer Therapy: What Is Available and What Is Yet to Come;Pharmacological Reviews;2016-06-30